Symbols

LMRI

Lumexa Imaging·NASDAQ

--(--)

LMRI fundamentals

LMRI Q4 2025 Earnings

Lumexa Imaging (LMRI) released its earnings on Mar 26, 2026: revenue was 260.65M (YoY --), missed estimates; EPS was 0.0605 (YoY --), beat estimates.

Revenue / YoY

260.65M

EPS / YoY

0.0605

Report date

Mar 26, 2026

LMRI Earnings Call Summary for Q4,2025

Strong Q4 Performance: Revenue +7.9%, EBITDA +18.6%, driven by advanced imaging and Fast Scan adoption.
2026 Growth Plan: 8-10 new centers, expansion of BAC and PET services, AI-driven efficiency gains.
Financial Strength: Leverage reduced to 3.5x, $50M annual interest savings, and 2026 EBITDA guidance of +5-7%.
Q1 Challenges: Flat EBITDA due to weather and volume pull-forward, but confident in full-year recovery.
Innovation Focus: AI partnerships, Virtual Cockpit, and 66% Fast Scan adoption by year-end.

Earnings

EPS

Revenue

Revenue & Expenses

LMRI has released its 2024 Q4 earnings report, with revenue of 248.03M, reflecting a YoY change of NaN%, and net profit of -25.06M, showing a YoY change of NaN%. The Sankey diagram below clearly presents LMRI's revenue sources and cost distribution.

Key Indicators

Lumexa Imaging (LMRI) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Lumexa Imaging (LMRI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Lumexa Imaging (LMRI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Lumexa Imaging (LMRI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown